We share data on 40 big-yield preferred stock ETFs and CEFs, including a special focus on the popular ETF, PFF (current yield is 5.8%).Read full newsRead More
The following slide deck was published by Temenos AG in conjunction with their 2022 Q4 earnings call.Read full newsRead More
Bridgewater Bancshares' stock price appears overvalued and does not reflect its intrinsic value. Click here to read why I recommend a hold rating on BWB stock.Read full newsRead More
Dropbox fell 11% in Friday's trading following the 4Q22 results release. Click here to read our analysis and why we think DBX stock is a buy.Read full newsRead More
Vanguard's Consumer Staples ETF is a relatively low-cost sleep well at night fund that can be a shelter during market volatility. Click for our VDC analysis.Read full newsRead More
The following slide deck was published by Lazard Ltd in conjunction with their 2022 Q4 earnings call.Read full newsRead More
Prologis has proven that it can deliver great results and grow its portfolio. Click here to read my analysis of PLD stock and why it's a hold.Read full newsRead More
The following slide deck was published by Intercontinental Exchange, Inc.Read full newsRead More
UnitedHealth Group's recent drawdown presents a lucrative investment opportunity to value-seeking investors. Read for a full investment analysis of UNH stock.Read full newsRead More
Wells Fargo was a long-term favorite of Warren Buffett, but he recently sold all his shares. Click here to see our take on WFC stock.Read full newsRead More
Passive index investing almost invariably outperforms other investment approaches. Click here to find out my entire portfolio and portfolio allocations.Read full newsRead More
Exxon Mobil Corporation has continued to grow its portfolio, particularly XOM's production in both Guyana and the Permian. Read for our take on XOM stock now.Read full newsRead More
Recent acquisitions help Fulgent Genetics expand horizontally and vertically. Click here to read my analysis of FLGT stock and why it's a hold.Read full newsRead More
The following slide deck was published by AbbVie Inc.Read full newsRead More
I show why factor momentum doesn't work and why it's hard to get good fills. I talk about the non-persistence of growth and how to use volatility to help measure market impact.Read full newsRead More
Rithm's Series D preferreds come with $1.75 annual coupon which currently forms 8.27% yield on cost. See why I intend to own Rithm preferreds for the long term.Read full newsRead More
Verallia is the third largest producer of glass bottles and jars. Almost half of its bottles are sold to the wine and sparkling wine industry. Read more here.Read full newsRead More
As anticipated, year-over-year earnings growth for stocks in the S&P 500 has flatlined and dipped into negative territory based on 4Q 2022 earnings reports.Read full newsRead More
The Mosaic Company is about to report Q4 earnings. I argue that in 2023, the MOS potash segment will be significantly weaker than in 2022. Click for more.Read full newsRead More
Xeris Biopharma expects to report record net product revenue for 2022. Read more to see my thoughts on XERS stock and my strategy and plans for 2023.Read full newsRead More